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1.  INTRODUCTION 
Sarcopenia is a geriatric syndrome associated with ageing that is characterised by a 
progressive loss of skeletal muscle mass and muscle function.[1]  It is known to increase the 
risk of disability, falls and falls-related injuries, loss of independence, hospitalisation, and 
mortality [2-5].  
In 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) 
recommended that both low muscle mass and low muscle function (muscle strength or 
physical performance) must be present for an individual to be diagnosed with sarcopenia.[1] 
Recently, the International Sarcopenia Initiative confirmed the applicability of the EWGSOP 
measurement tools for varied populations and highlighted a shortcoming in research looking 
at prevalence and risk factors among populations that are highly vulnerable to sarcopenia, 
such as within an acute or institutional setting.[6]  
Until the development of a consensus definition and measures, the prevalence of sarcopenia 
has varied widely from 7% to over 50% in middle to old aged adults.[7]  A review of studies 
employing the EWGSOP criteria has shown prevalence to be from 1% to 29% in community 
living adults, and 14% to 33% among Dutch and Italian adults residing in nursing homes.[6, 
8] Among older adults living in Italian nursing homes, Landi et al. using the EWGSOP 
criteria reported a high prevalence of 33%, with body mass index (BMI), gender, daily 
exercise and osteoarthritis identified as predictive risk factors.[8] Supporting this, Smoliner et 
al. confirmed BMI as a dominant risk factor to sarcopenia among in-patients in an acute 
geriatric hospital ward.[9] However, work in this area is still sparse, especially in populations 
of very old adults with low capacity in activities of daily living. The aim of the study was to 
assess the prevalence of sarcopenia, and identify the risk factors associated with sarcopenia 
among older adults permanently living in the long-term nursing home setting. 
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2. METHODS 
2.1 Study Design and Recruitment 
A cross-sectional survey to measure the prevalence of sarcopenia and associated risk factors 
in older people permanently living in nursing homes located in Australia. The homes were 
within one large aged care provider.  A detailed account of the recruitment and assessment 
methods has been published previously.[10] In brief, eleven facilities agreed to participate.  
Facility residents were included if they were (i) aged ≥ 60 years, (ii) residing in a nursing 
home and (iii) could provide informed consent, or if unable, proxy-informed consent could be 
obtained from their substitute decision maker. They were excluded if they (i) had a 
pacemaker, (ii) were end-stage palliative or terminal (iii), had difficult or dangerous 
behaviours or (iv), had medical or other issues that would limit data collection. Of all eligible 
residents, a representative sample was randomly selected to the study using a random number 
generator within the strata of level of care (low care, high care, or people with dementia 
residing in a secure dementia unit) to ensure a representative sample across strata. The levels 
of care are categorised according to the Australian Government Aged Care Funding 
Instrument (ACFI). Approval for the study was provided by the Human Research Ethics 
Committees of the participating aged care organisation and Universities. 
2.2 Measures 
Data were collected in a single assessment at each facility by an accredited exercise 
physiologist (AEP). All measures have been validated for use among the older 
population.[10] Data collected from facility records included demographics, ACFI level of 
care, date of admission, and facility recorded history of falls over the previous six months, 
number and type of diseases and medications, hospital admissions over the previous 12 
months, current and past smoking status. A fall was defined as ‘an event resulting in a person 
coming to rest unintentionally on the ground or lower level’.[11] Body weight and height 
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were measured using calibrated electronic scales and stadiometer to the nearest 0.1 kg and 0.1 
cm, respectively. Body mass index (BMI, kg/cm2) was calculated from weight and height.  
2.2.1 Primary Outcome: Sarcopenia 
Sarcopenia was defined according to the EWGSOP criteria. This requires the presence of 
both low muscle mass and low muscle function (muscle strength or physical performance).[1] 
Under these criteria, sarcopenia can be categorised as pre-sarcopenia (low muscle mass 
alone), sarcopenia (low muscle mass with low muscle strength or physical performance) and 
severe sarcopenia (low muscle mass with low muscle strength and physical performance). 
The cut-off points for diagnosis are (1) low muscle mass (SMI < 8.87 kg/m2 in men and < 
6.42 kg/m2 in women), (2) low muscle strength from handgrip strength  (< 30 kg in men and 
< 20 kg in women), and (3) low physical performance assessed by the short physical 
performance battery (SPPB) 2.4m walk test of ≤ 0.8m/s.[1]  Body resistance (Ohms - Ω) was 
measured using a Maltron BF-906 bioelectrical impedance analysis (BIA) device (Maltron 
International Ltd, UK). Body resistance was converted to skeletal muscle mass (SMM) using 
the Janssen et al.[12] validated equation:  
SMM (kg) = [height (cm)2 / BIA resistance (Ω) × 0.401) + (gender × 3.825) + (age 
(years) × −0.071)] + 5.102. 
The skeletal muscle mass index (SMI) was calculated by dividing SMM by height squared 
(kg/m2).[1] In addition, muscle mass (kg) and percent body fat data were generated by BIA 
assessment.[13] Muscle strength was measured by Jamar handgrip dynamometer (Sammons 
Preston Rolyan, IL). Physical performance was assessed using the SPPB 2.4 metre walk 
(metres per second).[14]  
2.2.2 Secondary Outcomes 
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In addition to the 2.4 m walk, the remaining SPPB measures were collected, namely, the 
hierarchical test of standing balance, and the five-time repeated chair stand measures.[14] 
Nutritional status was assessed by the Mini-Nutritional Assessment Instrument (MNA) short 
form.[15] A score greater than 12 from 14 points were deemed to have normal nutritional 
status, 8-11 as risk of malnutrition, and less than 8 as malnourished.[16, 17] Mood and 
cognitive status were rated using the Geriatric Depression Scale (GDS-15)[18] and the Mini-
Mental State Examination tool (MMSE)[19] respectively. The level of physical activity was 
assessed by the International Physical Activity Questionnaire-Short Form (IPAQ) which 
assesses four levels of activity (vigorous, moderate, walking, sitting) over a 7-day period.[20] 
Total physical activity (MET-minutes/week) was determined by summing the estimated 
metabolic equivalent energy expenditure within each activity level.  
2.3 Statistical Analysis 
Assuming a proportion of 30% based on the study by Landi etal.[8], a precision of 10%, and 
an estimated design effect of 2 to account for differences between the nursing home facilities, 
a sample size of 161 participants was required. Participant characteristics were analysed 
using descriptive statistics and presented as mean and SD for continuous variables, and 
counts and percentages for categorical variables. The characteristics of participants with 
sarcopenia and without sarcopenia were compared according to data distribution by one-way 
analysis of variance or the Mann-Whitney test. Categorical variables were compared using 
the Chi-square test. A p < 0.05 was considered to be statistically significant. Risk factors 
were determined by the use of logistic regression with sarcopenic status as the outcome. 
Univariable analysis was used initially to identify predictors of sarcopenia. Those factors that 
were significant at the 0.10 level were included in a multivariable model to determine which 
combination of factors best predicts sarcopenic status. Backwards stepwise regression was 
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used, with a statistical significance level of p < 0.05 for the final set of factors.  All analyses 
were conducted using Stata 11.2 (StataCorp). 
3.0 RESULTS 
3.1 Recruitment and Characteristics of Study Participants 
Of the 709 adults living in the 11 participating facilities, 328 were ineligible due to having a 
fitted pacemaker (3%), end-stage disease (8%), dangerous behaviours (31%), medical or 
other problems that made participation challenging (58%). From the 381 eligible residents, 
273 were randomly selected within the strata of high (58%) and low (29%) health care needs, 
and residing in a dementia unit (13%), and invited to participate, of which 102 individuals 
consented to participate, including 11 by proxy. A detailed overview of participant 
recruitment and characteristics has been presented elsewhere.[10] Participants were aged 84.5 
± 8.2 years with 70% female. On average, participants had resided for 39.8 ± 40.3 months 
with 85 individuals (83%) classified as high care by the ACFI. Over a quarter of participants 
had experienced a fall in the previous 6 months, and over a third had a hospitalisation in the 
previous year. Participant characteristics are depicted in Table 1.  
3.2 Sarcopenia  
Participants had a mean SMI of 7.7 ± 2.3 kg/m2, hand grip strength of 16.5 ± 7.7 kg and gait 
speed of 0.37 ± 0.23 m/s. Forty one (40.2%) participants were classified as being sarcopenic, 
among whom 95% had severe sarcopenia (Fig. 1). Males (48%) were more likely to be 
sarcopenic than females (37%). The majority of residents had below normal physical 
performance (97%) and below normal muscle strength (87%). Compared to non-sarcopenic 
participants (Table 2), sarcopenic individuals had a lower BMI (24.8 ± 1.9 kg/m2 vs 29.0 ± 
4.8 kg/m2, p<0.001), hand grip strength (14.2 ± 6.6 kg vs 17.9 ± 8.1 kg, p=0.02), and SPPB 
summary scores (2.9 ± 1.9 vs 3.8 ± 2.6, p=0.05). In addition, sarcopenic individuals had 
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higher GDS scores (6.3 ± 3.7 vs 4.6 ± 3.7, p = 0.04), reported more sitting time (13.7 ± 2.2 
hours/day vs 12.4 ± 3.3 hours/day, p=0.04), were less likely to report being currently physical 
active (25.6% vs 74.3%, p=0.04) and were more likely to be malnourished (p=0.03). 
3.3 Secondary outcomes 
Anthropometric measures showed the cohort had a BMI approaching obesity (27.3 ± 5.7 
kg/m2), high body fat (35.7 ± 11.7%) and a low SPPB summary score (3.5 ± 2.4).  Only 77 
participants could complete the standing balance test, and 27 were able to complete the chair 
standing task (20.9 ±5.4 sec). Eighty-four percent had a low IPAQ categorical score, with an 
average sitting time of 12.9 ± 3.0 hours per day.  Participants overall had mild cognitive 
impairment (MMSE 20.9 ± 6.4) and mild depression (GDS 5.2 ± 3.8), with 44 (45.9%) 
participants having moderate to severe cognitive impairment.  The majority of participants 
were at risk of malnourishment (48.5%), and 14.9% were malnourished. 
A number of variables (Age category, sex, hospital admissions in previous 12 months, length 
of hospital stay (mths), smoking status, BMI, SPPB total, MMSE category, GDS category, 
whether physically active at <50 yrs, whether physically active post retirement, any 
diagnoses, falls in previous 6 months, sitting time (IPAQ), ACFI category) were considered 
for logistic regression to identify factors that could impact on risk of sarcopenia.  
Variables entered as univariate predictors found an increased risk of sarcopenia (Table 3) for: 
BMI (Odds Ratio (OR) = 0.86; 95% Confidence Interval (CI) 0.78-0.94), SPPB summary 
score (OR = 0.83; 95% CI 0.69-1.00), MNA (OR = 0.19; 95% CI 0.05-0.68) and IPAQ sitting 
time (OR = 1.18; 95% CI 1.00-1.39). When the model was adjusted simultaneously for all 
variables in a multivariate logistic regression, only BMI remained significant (OR = 0.80; 
95% CI 0.65 – 0.97).  
4. DISCUSSION 
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Our findings demonstrate that the prevalence of sarcopenia is high (40.2%) among older 
adults living in nursing homes, with the majority presenting with severe sarcopenia. 
Sarcopenia was more prevalent in males than in females. Multivariate analysis identified 
decreasing BMI to be a significant predictor of increasing sarcopenic risk among the 
participants.  
A high level of prevalence of sarcopenia within nursing homes using the EWGSOP criteria 
was also assessed in a study by Landi et al.[8]  at 32.8% (n=122, age = 84.1± 4.1 years). Few 
other studies have investigated institutional settings, those that have reported prevalence as 
low as 14.3 – 17.3%, have been based on substantially younger populations.[6, 21] In 
comparison, community-dwelling older adults have a prevalence of 1 – 29%.[6]  Our findings 
demonstrate that residents in nursing homes have at least double the prevalence of sarcopenia 
compared to community-dwelling adults and those in acute geriatric hospital wards. 
Gianoudis and colleagues found in community-dwelling adults that for each 1-hour increment 
in overall daily sitting time, there was a 33 % increased risk of having sarcopenia.[22] Our 
study found that older adults living in nursing homes have high levels of sedentary 
behaviour.[23] Sedentary behaviour in older adults has been associated with reduced 
functional fitness required to perform normal everyday activities [24], and increased 
disability in activities of daily living (ADL)[25].  
Low lower limb strength, malnourishment, and poor physical performance were identified 
risk factors for sarcopenia in studies prior to the development of the EWGSOP criteria.[4] In 
our study, we assessed self-reported nutritional status, with 15% reporting malnourishment, 
and 49% being at risk of malnourishment. The mean BMI was 27 kg/m2, but was 24.8 kg/m2 
in residents with sarcopenia. Univariate regression analyses after control of potential 
confounders showed BMI, physical performance, sitting time, and nutritional status were 
associated with the presence of sarcopenia. The association of these factors with sarcopenia 
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could be the effect of inactivity on muscle strength and physical performance. In addition, 
there may be inadequate protein intake for the formation and maintenance of fat-free muscle 
mass.[26] After incorporating these variables into a multivariate regression analyses, only 
BMI remained predictive of sarcopenic status. BMI has previously been identified as a risk 
factor independently associated with sarcopenia among institutionalised and hospitalised 
older adults. [8, 9]  
Given the high prevalence of sarcopenia in nursing home residents, it is imperative to 
develop and implement evidence-based interventions into clinical practice.[27] Interventions 
to prevent or reduce sarcopenia include exercise interventions to increase muscle strength and 
improve physical performance, and nutritional interventions to increase protein synthesis, or 
a combination. A recent Cochrane review (2013) of physical rehabilitation in long-term care 
[28] found a small improvement on gait speed and a beneficial effect on muscle strength. The 
authors concluded that physical rehabilitation may be effective, but effects are small, and 
large scale trials of interventions are required.[28] A strength of the current study is that it 
recruited across eleven nursing homes, and all participants were randomly selected within 
strata of high and low care needs to achieve a representative sample. By employing the 
EWGSOP algorithm, this study can be compared to other prevalence studies across settings 
that utilise this criterion.  
That two-thirds of randomly selected residents declined to participate may limit the 
generalizability of this study and under-estimate the prevalence of the sarcopenia in this 
setting. The EWGSOP selected BIA as it is the most valid, reliable and feasible method of 
measuring muscle mass within field settings.[29] However, compared to Dual-energy X-ray 
absorptiometry, BIA may overestimate muscle mass, leading to an underestimation of the 
prevalence of sarcopenia.[29, 30] Due to the extent of missing data on disease status and 
medications during data collection, this data was considered unreliable and not included in 
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the logistic regression analyses. However, hospital admission and length of stay was included 
which could be regarded to act as a surrogate for disease status. The absence of these 
variables from the model may reduce the strength of the model in predicting sarcopenia. 
This study is only of a few to evaluate the prevalence and risk factors of sarcopenia within 
the nursing home setting using the EWGSOP criterion and the first in Australia. In 
conclusion, sarcopenia is highly prevalent in nursing homes, with low BMI being a 
significant risk factor, and provides a rationale for the development and evaluation of 
effective, feasible, transferable and sustainable interventions (exercise and nutritional 
interventions alone or in combination) implemented in nursing home settings.  
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Fig 1. Diagnosis of Sarcopenia according to the EWGSOP algorithm  
Notes: SMI, skeletal mass index. 
 
Participants (n=102) 
Normal Gait Speed  
≥ 0.8 m/s 
n = 3 
Low SMI 
< 8.87 kg/m2 for male 
< 6.42 kg/m2 for female 
n = 41 
Measure Muscle Mass  
(with Bioimpedance analysis) 
n = 101 
No sarcopenia 
n = 1 
Normal 
≥30 kg for male 
≥20 kg for female 
n = 1 
 
Hand Grip Strength 
Measurement 
Low Gait Speed  
< 0.8 m/s 
n = 99 
Low 
<30 kg for male 
<20 kg for female 
n = 2 
 
Normal SMI 
≥ 8.87 kg/m2 for male 
≥ 6.42 kg/m2 for female 
n = 60 
No sarcopenia 
n = 60 
Sarcopenia 
n = 41 (40.2%) 
Table 1: Characteristics of residential aged care participants 
 
Total 
(n= 102) 
Female 
(n= 71) 
Male 
(n= 31) 
Age (years) 84.5 ± 8.2 85.8 ± 8.0 82.1 ± 8.3 
Smoking Status (n, %)   Current 10 (10.2) 7 (10.4) 3 (9.7) 
   Former 42 (42.9) 23 (34.3) 19 (61.3) 
   Never 46 (46.9) 37 (55.2) 9 (29.0) 
Median length of stay in facility (mo) 29.7 (2.1-236.9) 34.7 (2.1-236.9) 18.8 (2.5-128.6) 
High Care by ACFI (%) 83.3 87.1 81.7 
Falls History in past 6 mths (%) 26.4 29.6 19.4 
Hospitalisation in past 12 mths (%) 34.3 35.4 33.8 
BMI (kg/m2) 27 ± 5.7 28 ± 6.1 26 ± 4.4 
Fat Mass (%) 36 ± 11.7 38 ± 10.8 28 ± 10.4 
Skeletal muscle mass index (kg/m2) 7.7 ± 2.3 7.2 ± 2.2 8.9 ± 1.9 
Hand grip strength (kg) 16.5 ± 7.7 14.7 ± 6.5 20.7 ± 8.9 
Gait speed (m/s) 0.37 ± 0.23 0.39 ± 0.23 0.31 ± 0.21 
Chair Stands (s)1 20.9 ± 5.4 20.3 ± 6.0 22.1 ± 4.1 
SPPB summary score 3.5 ± 2.4 3.8 ± 2.6 2.7 ± 1.9 
Physically active (n,%)   Current 39 (39.8) 30 (44.8) 9 (29.0) 
   Post-retirement 78 (76.5) 55 (77.5) 23 (74.2) 
IPAQ (N)  Low (< 600 ) 81 53 28 
  Mod (600-1499) 12 10 2 
  High (≥ 1500) 4 3 1 
IPAQ Total (Met-mins/wk) 369.5 ± 729.9 406.8 ± 715.8 288.8 ± 765.1 
IPAQ sitting time (hours/day) 12.9 ± 3.0 12.7 ± 3.3 13.3 ± 2.3 
MMSE  Severe (n) 4 (4.2) 3 (4.5) 1 (3.3) 
  Moderate (n) 40 (41.7) 24 (36.4) 16 (53.3) 
  Mild (n) 16 (16.7) 13 (19.7) 3 (10.0) 
  Normal (n) 36 (37.5) 26 (39.4) 10 (32.3) 
 Total 20.9 ± 6.4 21.3 ± 6.6 20.2 ± 5.9 
GDS 5.2 ± 3.8 4.6 ± 3.4 6.6 ± 4.3 
MNA (n, %)   Malnourished 15 (14.9) 12 (17.1) 3 (9.7) 
   At risk 49 (48.5) 31 (44.3) 18 (58.1) 
   Normal 37 (36.6) 27 (38.6) 10 (32.3) 
ABC 67.0 ± 32.2 69.7 ± 34.7 61.0 ± 24.0 
Sarcopenia (n, %) 41 (40.2) 26 (36.6) 15 (48.4) 
Results are expressed as means ± SD unless otherwise stated. BMI = body mass index; SPPB = Short Physical 
Performance Battery; IPAQ = International Physical Activity Questionnaire; MMSE = Mini-Mental State 
Examination; GDS = Geriatric Depression Scale; MNA = mini-nutritional assessment, ABC = Activity-Specific 
Balance Scale 
Table 2: Characteristics of Older Adults by Sarcopenia Status 
 No sarcopenia (n= 61) Sarcopenia (n= 41) p-value 
Age (years) 83.5 (8.3) 86.0 (7.8) 0.14 
Education (n, %)    
  Primary school 30 (65.2) 16 (34.8) 0.88 
  High school 20  (55.6) 16  (44.4)  
  Tertiary 9 (64.3) 5 (35.7)  
  Unknown 3 3  
Smoking Status (n, %) 8 (80) 2 (20) 0.47 
Falls History in past 6 mths (%) 22 (57.9) 16 (42.1) 0.76 
Hospitalisation in past 12 mths (%) 20 (57.1) 15 (42.9) 0.59 
BMI (kg/m2) 29.0 (4.8) 24.8 (1.9) <0.001 
Hand grip strength (kg) 17.9 (8.1) 14.2 (6.6) 0.02 
Gait speed (m/s) 0.39 (0.03) 0.33 (0.03) 0.16 
Total SPPB score 3.8 (2.6) 2.9 (1.9) 0.05 
Physically active (n,%)    
  Current 29 (74.3) 10 (25.6) 0.04 
  Post-retirement 49 (62.8) 29 (37.2) 0.82 
IPAQ Categorical Score (Met-mins/wk)    
  Low (< 600 ) 50 (61.7) 31 (38.3) 0.84 
  Mod (600-1499) 7 (58.3) 5 (41.7)  
  High (≥ 1500) 3 (75.0) 1 (25.0)  
IPAQ sitting time (hours/day) 12.4 (3.3) 13.7 (2.2) 0.04 
MMSE 21.6 (6.3) 19.9 (6.4) 0.20 
MMSE Level of Cognitive Impairment    
  Severe  25 (69.4) 11 (30.6) 0.64 
  Moderate 9 (56.3) 7 (43.8)  
  Mild 23 (57.5) 17 (42.5)  
  Normal 3 (75.0) 1 (25.0)  
GDS 4.6 (3.7) 6.3 (3.7) 0.04 
MNA Category    
  Malnourished 5 (33.3) 10 (66.7) 0.03 
  At risk 30 (61.2) 19 (38.8)  
  Normal 27 (73.0) 10 (27.0)  
Results are expressed as means (SD) unless otherwise stated. BMI = body mass index; SPPB = 
Short Physical Performance Battery; IPAQ = International Physical Activity Questionnaire; MMSE 
= Mini-Mental State Examination; GDS = Geriatric Depression Scale; MNA = mini-nutritional 
assessment. 
 
Table 3 Logistic Regression Models of Risk of Sarcopenia 
Factor Univariate Odds Ratio (95% CI) p-value 
BMI 0.86 (0.78-0.94) 0.001 
Total SPPB 0.83 (0.69-1.00) 0.05 
IPAQ sitting time 1.18 (1.00-1.39) 0.05 
MNA 0.19 (0.05-0.68) 0.01 
MNA Category   
Poor 1.0 (referent)  
At risk 0.32 (0.09-1.07) 0.06 
Good 0.19 (0.05-0.68) 0.01 
Factor Multivariate (Adjusted) Odds Ratio (95% CI) p-value 
BMI 0.80 (0.65-0.97) 0.03 
Total SPPB 0.82 (0.49-1.37) 0.45 
IPAQ sitting time 1.20 (0.78-1.83) 0.40 
MNA Category   
Poor 1.0 (referent)  
At risk 2.52 (0.10-61.3) 0.57 
Good 2.91 (0.09-94.7) 0.55 
Notes: BMI, body mass index; SPPB,  Short Physical Performance Battery; IPAQ, International Physical Activity 
Questionnaire; MNA, Mini-Nutritional Assessment, OR, odds ratio. 
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